Loading...

TVGN TEVOGEN BIO HOLDINGS INC Delisting Actions 8-K Filing

TVGN

TVGN

TEVOGEN BIO HOLDINGS INC

(TVGN)

2026 8-K

Delisting Notice

Stock Compliance Regained

Reverse Stock Split

Stockholder Approvals

Special Cash Dividend

Nasdaq Compliance Notice

Equity Offerings

Geographic Expansion

Management Changes

Management Changes

Grant Announcement

Stock Purchase Agreement

Entry into a Material Defin...

Loan Agreement with The Pat...

Amendment to Financial Stat...

Term Sheet Agreement

Appointment of Independent ...

Amendment to Financial Stat...

Financial Results Announcement

Amendment to Filing

Securities Purchase Agreement

Filing of Certificate of De...

Code of Business Conduct an...

Amendment to Previous Report

Merger of Equals

Shareholder Meeting

Merger Announcement

Amendment and Extension App...

Merger of Equals

Compliance with Nasdaq MVLS...

Merger Agreement

Merger Agreement

Purchase Agreement

Agreements and Delisting

Delisting Notice

Charter Amendment Approval

Conversion of Class B share...

Proxy Statement for EGM

External Links:

Tevogen Bio Holdings Inc. was notified on April 16, 2026, that it no longer meets Nasdaq’s $50 million market value requirement for continued listing, along with a $15 million requirement for publicly held shares. The company has until October 13, 2026, to regain compliance and may consider options for this.

AI Assistant

TEVOGEN BIO HOLDINGS INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.